Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Baltimore, MD

107 studies for Prostate Cancer are recruiting at 187 sites within 50 miles of Baltimore, Maryland, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Baltimore.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Baltimore

Showing the 50 nearest of 107 studies.
  1. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD); Maryland Proton Treatment Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  2. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: MedStar Franklin Square Medical Center/Weinberg Cancer Institute (Baltimore, MD); Mercy Medical Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  3. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    NCT06136650

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baltimore Veterans Affairs Medical Center ( Site 0069) (Baltimore, MD); Greenebaum Comprehensive Cancer Center ( Site 0049) (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  4. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    NCT07200830

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Maryland Proton Treatment Center (Baltimore, MD); University of Maryland/Greenebaum Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  5. TERPS Trial for de Novo Oligometastic Prostate Cancer

    NCT05223803

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Maryland Proton Treatment Center (Baltimore, MD); UMMC (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  6. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT07225946

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins Hospital (Baltimore, MD); Johns Hopkins Medical Institutions (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  7. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (Baltimore, MD); Massive Bio SYNERGY-AI site (Towson, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  8. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    NCT04423211

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD); Suburban Hospital (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  9. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD); George Washington University Medical Center (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  10. Study of ORIC-944 in Patients With Metastatic Prostate Cancer

    NCT05413421

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland (Baltimore, MD); Maryland Oncology Hematology (Silver Spring, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  11. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Johns Hopkins University (Baltimore, MD); Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  12. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    NCT04787744

    • Phase 2/3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD (Baltimore, MD); Washington DC VA Medical Center, Washington, DC (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. Clinical Trial of Approaches to Prostate Cancer Surgery

    NCT05155501

    • Interventional
    • Ages 40 to 80 years
    • Sex: Male

    Nearest sites: Johns Hopkins University (Baltimore, MD); Georgetown University (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Sidney Kimmel Comprehensive Cancer Center at John Hopkins (Baltimore, MD); NEXT Virginia (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    NCT05919264

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD); Johns Hopkins University, Sibley Memorial Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

    NCT05939414

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Johns Hopkins Kimmel Com Cancer Ctr (Baltimore, MD); University of Maryland Medical Ctr (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    NCT06136624

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baltimore Veterans Affairs Medical Center ( Site 0069) (Baltimore, MD); Greenebaum Comprehensive Cancer Center ( Site 0049) (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

    NCT06257693

    • Phase 1
    • Ages 21 years and older
    • Sex: Male

    Nearest sites: Johns Hopkins University School of Medicine (Baltimore, MD); National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

    NCT06785636

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Johns Hopkins Hospital (Baltimore, MD); NEXT Oncology - Virginia (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    NCT06925737

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Greenebaum Comprehensive Cancer Center ( Site 0021) (Baltimore, MD); Washington DC Veterans Affairs Medical Center ( Site 0056) (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

    NCT07213674

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center (Baltimore, MD); University of Maryland Greenebaum Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. Transrectal Ultrasound Robot-Assisted Prostate Biopsy

    NCT02871726

    • Interventional
    • Ages 45 to 75 years
    • Sex: Male

    Nearest site: Johns Hopkins Hospital (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. International Registry for Men With Advanced Prostate Cancer (IRONMAN)

    NCT03151629

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest site: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

    NCT03861676

    • Early Phase 1
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: SKCCC at Johns Hopkins (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

    NCT04363164

    • Phase 2
    • Ages 18 to 90 years
    • Sex: Male

    Nearest site: Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

    NCT04489719

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

    NCT04503265

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Johns Hopkins (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT04704505

    • Phase 2
    • Ages 18 years and older
    • Sex: Male
    • Accepts healthy volunteers

    Nearest site: Amber Michalik (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

    NCT04995198

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

    NCT05125016

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Maryland Greenebaum Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #14 (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    NCT05519449

    • Phase 1
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: University of Maryland Greenebaum Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

    NCT05691465

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

    NCT06059118

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

    NCT06138067

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Exercise in Prostate Cancer

    NCT06165302

    • Interventional
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

    NCT06172478

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

    NCT06389097

    • Observational
    • Ages 18 to 100 years
    • Sex: All

    Nearest site: Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

    NCT06616597

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    NCT06778863

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

    NCT06801236

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Maryland, Greenebaum Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. 7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

    NCT06826924

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

    NCT06855277

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Johns Hopkins Hospital (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. The COSMYC Trial (COmbined Suppression of MYC)

    NCT06922318

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

    NCT07142551

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Physician- and Patient-based Barriers to NGS Testing

    NCT07209176

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe

    NCT07271017

    • Phase 1
    • Ages 40 to 75 years
    • Sex: Male

    Nearest site: Johns Hopkins Hospital (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

    NCT07550517

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

    NCT07543757

    • Observational
    • Ages 40 to 75 years
    • Sex: Male

    Nearest sites: Chesapeake Urology Associates (Towson, MD); Chesapeake Urology Associates (Hanover, MD)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  50. A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

    NCT04729114

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Chesapeake Urology (Towson, MD)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.